Araim Pharmaceuticals is a company focused on the discovery of a global master regulator, the Innate Repair Receptors (IRR), that produces cellular and tissue repair in various disease states. Its lead compound Cibinetide, is focused on addressing unmet needs in neuroscience and diabetes complications.